2PZY | pdb_00002pzy

Structure of MK2 Complexed with Compound 76


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free: 
    0.313 (Depositor) 
  • R-Value Work: 
    0.251 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 2PZY

This is version 1.2 of the entry. See complete history

Literature

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors

Wu, J.-P.Wang, J.Abeywardane, A.Andersen, D.Emmanuel, M.Gautschi, E.Goldberg, D.R.Kashem, M.A.Lukas, S.Mao, W.Martin, L.Morwick, T.Moss, N.Pargellis, C.Patel, U.R.Patnaude, L.Peet, G.W.Skow, D.Snow, R.J.Ward, Y.Werneburg, B.White, A.

(2007) Bioorg Med Chem Lett 17: 4664-4669

  • DOI: https://doi.org/10.1016/j.bmcl.2007.05.101
  • Primary Citation Related Structures: 
    2PZY

  • PubMed Abstract: 

    The discovery of a series of potent, carboline-based MK2 inhibitors is described. These compounds inhibit MK2 with IC50s as low as 10 nM, as measured in a DELFIA assay. An X-ray crystal structure reveals that they bind in a region near the p-loop and the hinge region of MK2a.


  • Organizational Affiliation
    • Research and Development, Boehringer-Ingelheim Pharmaceuticals, 900 Ridgebury Road, Ridgefield, CT 06877, USA. jwu@rdg.boehringer-ingelheim.com

Macromolecule Content 

  • Total Structure Weight: 151.43 kDa 
  • Atom Count: 9,585 
  • Modeled Residue Count: 1,169 
  • Deposited Residue Count: 1,296 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
MAP kinase-activated protein kinase 2
A, B, C, D
324Homo sapiensMutation(s): 0 
Gene Names: MAPKAPK2
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P49137 (Homo sapiens)
Explore P49137 
Go to UniProtKB:  P49137
PHAROS:  P49137
GTEx:  ENSG00000162889 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP49137
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
STU

Query on STU



Download:Ideal Coordinates CCD File
G [auth C]STAUROSPORINE
C28 H26 N4 O3
HKSZLNNOFSGOKW-FYTWVXJKSA-N
B18

Query on B18



Download:Ideal Coordinates CCD File
E [auth A],
F [auth B]
(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE
C21 H24 N6 O3 S
QWFFPYQWUWLDBV-NSHDSACASA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
STU BindingDB:  2PZY IC50: 1 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free:  0.313 (Depositor) 
  • R-Value Work:  0.251 (Depositor) 
Space Group: P 63
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 159.61α = 90
b = 159.61β = 90
c = 134.5γ = 120
Software Package:
Software NamePurpose
d*TREKdata processing
CNSrefinement
PDB_EXTRACTdata extraction
CrystalCleardata collection
d*TREKdata reduction
d*TREKdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2007-07-31
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Derived calculations, Version format compliance
  • Version 1.2: 2024-02-21
    Changes: Data collection, Database references